Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03193372 · ClinicalTrials.gov registry record
A Study of Patient Concerns and Treatment Satisfaction in Patients Being Treated With Finacea Foam for Rosacea
A clinical trial, sponsored by LEO Pharma.
- Completed
- Registry status
- 2,200
- Enrollment target
NCT03193372 is a clinical trial that has completed, run by LEO Pharma. The registered enrollment target is 2,200 participants.
The verdict
NCT03193372 has completed, sponsored by LEO Pharma.
- COMPLETED
- Registry status
- 2,200 participants
- Enrollment target
Study Summary
To survey rosacea patients about their concerns, treatment satisfaction, and quality of life associated with their Finacea Foam treatment
Interventions
- DRUG Azelaic Acid (Finacea Foam, BAY39-6251)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,200 participants |
| Start Date | 2017-07-20 |
| Est. Completion | 2017-11-15 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03193372
The ClinicalTrials.gov registry entry for NCT03193372 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 2,200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is LEO Pharma, which has 65 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Azelaic Acid (Finacea Foam, BAY39-6251) is the first listed.
NCT03193372 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03193372 about?
NCT03193372 is a clinical study titled "A Study of Patient Concerns and Treatment Satisfaction in Patients Being Treated With Finacea Foam for Rosacea". To survey rosacea patients about their concerns, treatment satisfaction, and quality of life associated with their Finacea Foam treatment
What is the current status of trial NCT03193372?
This trial is currently completed. The enrollment target is 2,200 participants. The study started on 2017-07-20. Estimated completion is 2017-11-15.
What interventions are being tested in trial NCT03193372?
The interventions under investigation include: Azelaic Acid (Finacea Foam, BAY39-6251) (DRUG).
Who is sponsoring clinical trial NCT03193372?
This trial is sponsored by LEO Pharma, which has 65 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.